Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Coeptis Therapeutics Holdings (COEPW) Shares Issued (2022 - 2025)

Historic Shares Issued for Coeptis Therapeutics Holdings (COEPW) over the last 4 years, with Q3 2025 value amounting to $3.0 million.

  • Coeptis Therapeutics Holdings' Shares Issued changed N/A to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 24819.84%. This contributed to the annual value of $500000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Shares Issued stood at $3.0 million.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Shares Issued peaked at $3.0 million during Q3 2025, and registered a low of -$2.5 million during Q4 2023.
  • In the last 4 years, Coeptis Therapeutics Holdings' Shares Issued had a median value of $300000.0 in 2023 and averaged $435518.4.
  • Examining YoY changes over the last 5 years, Coeptis Therapeutics Holdings' Shares Issued showed a top increase of 9242.42% in 2023 and a maximum decrease of 25409360000.0% in 2023.
  • Over the past 4 years, Coeptis Therapeutics Holdings' Shares Issued (Quarter) stood at $1.0 in 2022, then crashed by 254093600.0% to -$2.5 million in 2023, then surged by 119.68% to $500000.0 in 2024, then soared by 504.83% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $100.0 for Q2 2025, and $400.0 during Q1 2025.